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A novel synthetic route for the preparation of sulfamide- and 3-N-sulfamate-modiﬁed dinucleosides has been
developed. The synthesis utilises 4-nitrophenyl chlorosulfate to prepare 4-nitrophenyl 3- or 5-sulfamates (e.g., 18
and 27), which couple smoothly with the alcohol or amine functionalities of other nucleosides. The conformational
properties of the sulfamide- and 3-N-sulfamate-modiﬁed dinucleosides d(TnsnT) and d(TnsoT) were compared with
the native dinucleotide d(TpT) using NMR and CD spectroscopy. Whilst both modiﬁcations result in a shift in the
conformational equilibrium of the 5-terminal ribose rings from C2-endo to a preferred C3-endo conformation,
only the 3-N-sulfamate-modiﬁed dimer exhibits an increased propensity to adopt a base-stacked helical
conformation. Incorporation of the sulfamide- and 3-N-sulfamate modiﬁcations into the DNA sequence
d(GCGT10GCG) allowed the duplex melting temperature to be determined using UV thermal denaturation
experiments. This reveals that the sulfamide modiﬁcation signiﬁcantly destabilises duplexes with both
complementary DNA and RNA. However, the 3-N-sulfamate modiﬁcation has little eﬀect on duplex stability
and even stabilises DNA duplexes at low salt concentration. These results indicate that the 3-N-sulfamate group
is one of the most promising neutral replacements of the phosphodiester group in nucleic acids, that have been
developed to date, for therapeutic and other important applications.
Introduction
Nucleic acids have been extensively modiﬁed by replacing
the nucleobase, sugar, phosphodiester linkage or the whole
backbone with alternative structures.1–5 Evaluating the eﬀects
of the various structural modiﬁcations on the conformation
and recognition properties of nucleic acids can provide an
alternative perspective from which the structure and function
of native DNA and RNA can be better understood. More-
over, if the modiﬁcations investigated could potentially
have arisen under prebiotic conditions then it is possible to
speculate about the origins of the genetic material.6,7 Modiﬁed
oligonucleotides have also been developed as antisense or
antigene therapeutic agents.1–3 Similarly, modiﬁcation strategies
can be used to stabilise aptamers 8,9 or ribozymes 10,11 for
use in vivo via exogenous delivery. Furthermore, modiﬁed
nucleic acids also have signiﬁcant potential as diagnostic
agents or bio-analytical tools which depend upon hybridis-
ation.12 For example, novel microarrays have been developed
which utilise peptide nucleic acid probes.13 Here improved
stability, aﬃnity and sequence speciﬁcity can also be
advantageous.
In antisense and antigene research there has been consider-
able interest in the replacement of the phosphodiester group
of oligonucleotides with alternative neutral linkages that are
† Electronic supplementary information (ESI) available: typical melting
curves obtained from thermal denaturation of modiﬁed oligonucleo-
tides with complementary DNA and RNA. See http://www.rsc.org/
suppdata/p1/b1/b110603c/
stable to nuclease digestion and increase the lipophilicity of
backbone, possibly aiding cellular uptake.1–3 In addition it was
anticipated that introducing neutral linkages would improve
aﬃnity for complementary DNA and RNA, by reducing
electrostatic repulsion between stands. One of the earliest
examples of this class are the methylphosphonate-modiﬁed
oligonucleotides 1 (Scheme 1).14,15 Replacement of one of
the non-bridging oxygen atoms with a methyl group in 1 results
in a chiral phosphorus atom. Although the R-conﬁgured
methylphosphonates form duplexes which are as stable as iso-
sequential native duplexes, oligonucleotides consisting of a
mixture of diastereoisomers have relatively poor aﬃnity for
complementary nucleic acids.14 Despite this, eﬃcient synthetic
methodology for the enantioselective synthesis of mixed-
Scheme 1
1
PERKIN
DOI: 10.1039/b110603c J. Chem. Soc., Perkin Trans. 1, 2002, 485–495 485
This journal is © The Royal Society of Chemistry 2002
Pu
bl
ish
ed
 o
n 
29
 Ja
nu
ar
y 
20
02
. D
ow
nl
oa
de
d 
by
 N
O
RT
H
ER
N
 A
RI
ZO
N
A
 U
N
IV
ER
SI
TY
 o
n 
09
/0
3/
20
16
 0
0:
51
:2
2.
 
View Article Online / Journal Homepage / Table of Contents for this issue
sequence oligomers with all R stereocentres has yet to be
developed.15 Several neutral achiral phosphodiester replace-
ments have also been investigated, including methylene-
(methylimino) (MMI) 2,16 amide 3,2 and 3-thioformacetal 4,17
which exhibit good aﬃnity for nucleic acid targets and hold
more promise for the development of improved antisense
or antigene agents. Other neutral backbone modiﬁcations
have also been used in the development of oligonucleotides
with potentially diﬀerent modes of therapeutic action. For
example, dsDNA possessing an Eco RV restriction site was
modiﬁed with a single neutral dimethylenesulfone linkage
6.18 The resulting duplex adopts a bent conformation and
functions as a transition-state analogue inhibiting cleavage
of the native dsDNA substrate. Extension of this strategy
could lead to modiﬁed oligonucleotide inhibitors of other
enzymes that process native DNA substrates. Furthermore
a thrombin binding DNA aptamer, generated by in vitro
selection, was modiﬁed with formacetal linkages 5.9 The
modiﬁed chimeric oligonucleotide aptamer, which adopts a
chair-like structure, retains high aﬃnity for the protein target
but has considerably improved stability and anticoagulant
activity in vivo. Finally, methylphosphonate modiﬁcations 1
have also been used to probe protein–nucleic acid inter-
actions using a template-directed interference footprinting
approach.19
Recently we have been involved in the synthesis and evalu-
ation of backbone-modiﬁed nucleic acids.20–22 In particular we
have sought to develop modiﬁed oligonucleotides with neutral
sulfamide 7 and 3-N-sulfamate 8 groups replacing the
negatively charged phosphodiester linkage (Scheme 2).21,22 In
addition to possessing many of the advantageous properties
common to other neutral modiﬁcations 1–6, these linkages
should be easier to prepare and more closely resemble the
phosphodiester group both sterically and conformationally. In
the case of native nucleic acids anomeric or gauche eﬀects are,
at least in part, responsible for the conformational preferences
of the phosphodiester P–Oester bonds.
23 Similar stereoelectronic
eﬀects are likely to control the conformational properties of
the sulfamate and sulfamide linkages in 7 and 8. In addition the
tetrahedral nitrogen atoms, in these linkages, can potentially
invert conﬁguration, resulting in diﬀerent orientations of the
N–H bonds.23 In this paper we describe in detail the novel
synthesis of 3-N-sulfamate- and sulfamide-modiﬁed oligo-
nucleotides and examine the eﬀects of these modiﬁcation on
the backbone conformation and aﬃnity for complementary
DNA and RNA.
Scheme 2
Results and discussion
Synthesis of sulfamide- and 3-N-sulfamate-modiﬁed
dinucleosides
Previously we have shown that the 2-hydroxyphenyl sulfamate 9
(Scheme 2), derived from catechol sulfate, can be coupled with
5-amino nucleosides to give sulfamide-linked dinucleosides.22
However, these coupling reactions are slow, requiring heating
under reﬂux in 1,4-dioxane for extended periods and give only
moderate yields of sulfamide products. Moreover, treatment
of the 2-hydroxyphenyl sulfamate 9 with nucleoside 5-alcohols
in the presence of base fails to give any sulfamate products.
Aryl sulfamates 10 are thought to undergo elimination in the
presence of base to form N-sulfonylamines 12 via the anion 11
by an E1cB mechanism or directly through an E2-type pro-
cess.24 The highly electrophilic N-sulfonylamine 12 is then
trapped by nucleophiles, for example amines or alcohols,
resulting in sulfamides 13 or sulfamates 14, respectively. Given
that catechol is a relatively poor leaving group (pKa1 ≈ 9.1) 25 it
seems likely that, in the case of the 2-hydroxyphenyl sulfamate
9, the equilibrium between the sulfamate 10 or the conjugate
base 11 and N-sulfonylamine 12 lies on the side of the starting
material. As a consequence of this only more nucleophilic
amines can compete with catecholate, in the reverse reaction,
and trap the low concentration of N-sulfonylamine to give
sulfamide products 13. With this in mind we reasoned that
more reactive aryl sulfamates 10, sulfamoyl chlorides (RNH-
SO2Cl) or sulfamoyl azides (RNHSO2N3), would be required as
substrates for coupling with alcohols to give sulfamates 14.
Nucleosides with 5-sulfamoyl azide groups have been
employed previously in the synthesis of 5-N-sulfamate
dinucleosides.26 Nevertheless we chose to avoid this chemistry
given that it necessitates the use the explosive reagent sulfuryl
chloride azide and yields were low. Also, earlier attempts to
synthesise the sulfamoyl chloride 17 (Scheme 3) from 3-amino
nucleoside 15 using sulfuryl dichloride had failed. We therefore
chose to investigate the reaction of the 3-amine 15 with 4-
nitrophenyl chlorosulfate 16, anticipating the production of
either the sulfamoyl chloride 17 or the 4-nitrophenyl sulfamate
18. Accordingly, 4-nitrophenyl chlorosulfate 16 was prepared
using a modiﬁcation of an earlier method which involves treat-
ing 4-nitrophenol with sulfuryl dichloride and pyridine in
diethyl ether at low temperature.27 The resulting product 16, is
a crystalline solid which is relatively stable and can be safely
stored for several months under an inert atmosphere. Although
4-nitrophenyl chlorosulfate 16 has been known since 1948,28 it
has found little practical use in synthesis. Despite this the
mechanism of nucleophilic substitution reactions of 16 and
other aryl chlorosulfates has been investigated.29 These studies
Scheme 3
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show that nucleophilic attack at sulfur can result in either S–Cl
or S–OAr bond scission, with S–OAr bond cleavage the major
reaction pathway. Yet we found that the reaction of 3-amine 15
with a slight excess of 16 and triethylamine at room temper-
ature, or at 78 C, in a variety of diﬀerent solvents consist-
ently gave the symmetrical sulfamide dimer 19 as the major
product (ca. 58% yield). A minor amount of the 4-nitrophenyl
sulfamate 18 (19% yield) was also produced, but none of the
sulfamoyl chloride 17 was ever isolated. It seems likely, if
S–OAr bond cleavage is the major reaction pathway, that the
sulfamoyl chloride 17 generated in situ reacts with the 3-amine
15 to give the dimer 19. Presumably the presence of triethyl-
amine, which is necessary to avoid deprotection of the acid-
labile dimethoxytrityl group, results in elimination of chloride
from the more reactive sulfamoyl chloride 17 to give the
N-sulfonylamine, which is trapped by the 3-amine even at
78 C. Thus the less reactive 4-nitrophenyl sulfamate 18,
which was isolated, is probably derived from the minor reaction
pathway involving S–Cl bond cleavage. Attempts to prepare 17
were therefore abandoned. Instead we sought to increase the
yield of 4-nitrophenyl sulfamate 18 in order to investigate
coupling reactions with the 5-hydroxy group of other nucleo-
sides. We argued that by adding excess of 4-nitrophenol and
triethylamine to the reaction of 15 with 16 it may be possible to
intercept any N-sulfonylamine with 4-nitrophenoxide, thus pre-
venting formation of the unwanted symmetrical dimer 19. This
proved to be the case and 4-nitrophenyl sulfamate 18 could be
prepared in 68% yield, with no dimer 19, upon addition of 2
equivalents of chlorosulfate 16 to the 3-amine 15 along with a
large excess (10 equivalents) of nitrophenol and triethylamine.
The 4-nitrophenyl sulfamate 18 was then treated with a two-
fold excess of 5-alcohol 23 (Scheme 4) and 5 equivalents
of triethylamine, resulting in a near quantitative yield of the
sulfamate dinucleoside 24 after stirring at room temperature for
12 h. Clearly, nitrophenoxide (pKa = 7.1) 25 is a superior leaving
group compared with catecholate and this has a dramatic eﬀect
on the rate of nucleophilic substitution. This is consistent
with elimination of the aryloxide being the rate-determining
step in such reactions.24 Furthermore, the inclusion of dry 4Å
molecular sieves is also critical to the success of this coupling
reaction, particularly when performed on a small scale. Without
sieves yields were considerably diminished, presumably due to
competing hydrolysis and formation of a sulfamic acid side
product which was not isolated.
In order to investigate the combined eﬀects of 2-ﬂuoro as
Scheme 4
well as 3-N-sulfamate or sulfamide modiﬁcations on DNA
duplex stability we also prepared the 3-azido-2-ﬂuorouridine
derivative 20.30 Reduction of the azide to the amine 21 was
achieved in near quantitative yield with H2S in aq. pyridine.
31
Generally we have found this method to be superior, to hydro-
genolysis or other methods commonly used in the reduction of
5- and 3-azido nucleosides. Sulfomylation of the 3-amino-2-
ﬂuorouridine derivative 21, with the 4-nitrophenyl chlorosulfate
16 as described above, was more problematic, resulting in only
59% of sulfamate 22. For reasons that remain unclear all
attempts to couple sulfamate 22 with 5-alcohol 23 failed to give
any 2-ﬂuoro-3-N-sulfamate dinucleoside 25. Despite this we
were able to prepare the 2-ﬂuorosulfamide dinucleoside 29
(Scheme 5). This was achieved by sulfonylation of 5-amino
nucleoside 26 with 4-nitrophenyl chlorosulfate 16 (78% yield) to
give the 5-sulfamate 27 followed by coupling with 3-amino-2-
ﬂuorouridine 21 in the presence of triethylamine (80% yield).
Notably, the aminolysis of 4-nitrophenyl sulfamate 27 was
complete within 3 h at room temperature in contrast to the
rather more vigorous conditions required for aminolysis of
the corresponding 2-hydroxyphenyl sulfamate.22 Similarly, the
sulfamide dinucleoside 28 was prepared in 83% yield from
4-nitrophenyl sulfamate 27 and 3-amine 15. This was a con-
siderable improvement on the 56% yield obtained previously for
the coupling reaction between 3-amine 15 and the analogous
2-hydroxyphenyl sulfamate.22 Overall, these ﬁndings clearly
indicate that 4-nitrophenyl sulfamate nucleosides (e.g., 18 and
27) are signiﬁcantly superior building blocks, compared with
the 2-hydroxyphenyl sulfamates, for the synthesis of sulfamide-
as well as sulfamate-modiﬁed dinucleosides.
The synthesis was completed by desilylation of 3-N-
sulfamate and 2-ﬂuorosulfamide dinucleosides 24 and 29, with
TBAF, to give 3-alcohols 32 and 33 (Scheme 6), which were
phosphitylated using 2-cyanoethyl N,N,N,N-tetraisopropyl-
phosphorodiamidite and 4,5-dicyanoimidazole resulting in the
required phosphoramidites 35 and 36. These, along with the
sulfamide phosphoramidite 37, which was previously derived
from alcohol 34,22 were used in the subsequent solid-phase syn-
thesis of modiﬁed oligonucleotides. In addition a small portion
of the 3-N-sulfamate dinucleoside 32 was detritylated, using
dichloroacetic acid, to give the dinucleoside d(TnsoT) 30 which
was required for conformational studies.
Conformational properties of sulfamide- and 3-sulfamate-
modiﬁed dinucleosides
The conformational properties of the sulfamide dimer d-
(TnsnT) 31 were previously compared with those of the native
dinucleotide d(TpT) using NMR spectroscopy.22 Here the
Scheme 5
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conformational eﬀects of replacing the phosphodiester group
of d(TpT) with a 3-N-sulfamate group (30) are similarly
examined. Accordingly the 1H NMR spectrum of d(TnsoT) 30,
in D2O, was fully assigned with the aid of COSY and NOESY
experiments. From this the vicinal coupling constants J12
and J12 were then measured at various temperatures. The sum
of these coupling constants (Σ1) were used to determine the
approximate extent of the equilibrium, between the northern
(N) or C3-endo and the southern (S ) or C2-endo conform-
ation of the sugar rings using the method of Altona.32 This
revealed (Table 1) that the 5-terminal ribose ring of d(T nsoT)
exists predominantly in a northern sugar conformation (69% N
at 30 C), which was also found to be the case with d(T nsnT)
(66% N at 30 C). In contrast the 5-terminal ribose unit of the
native dinucleoside phosphate d(T pT) preferentially adopts a
southern conformation (36% N at 30 C). The observed shift
towards a preferred N-conformation is normally attributed to a
reduction in the gauche eﬀect between the 3-substituent and
the deoxyribose O4 atom, given that the 3-amino group
in d(T nsoT) and d(T nsnT) is more electropositive than the
3-oxygen atom of d(T pT),33–35 although other factors, such as
aqueous solvation, may also contribute to this conformational
eﬀect.23 The 3-terminal ring of d(TnsoT ) was 44% N at 30 C,
which is similar to that observed previously for d(TnsnT ) (42%
at 30 C) and slightly higher than for d(TpT ) (36% at 30 C).
Furthermore we observed that the % of N-conformer for the
5-terminal ring of d(T nsoT) increases upon lowering the tem-
perature from 63% N at 70 C to 78% N at 10 C. A similar
increase in % N had previously been observed for d(T nsnT).
This was attributed to a possible increased propensity of
the sulfamide modiﬁed dinucleoside to adopt a base-stacked
conformation at lower temperatures, given that intramolecular
base stacking is known to favour the N-ribose conformation in
dinucleoside phosphates.36,37
To further investigate the hypothesis that base stacking
occurs in the modiﬁed dinucleosides, circular dichrosim (CD)
spectroscopy was employed. It is well established that the inten-
sity of the CD signal of di- and oligonucleotides is highly
dependent on the proportion of molecules that exist in an
helical base-stacked conformation, as opposed to a random
conformation.38,39 Accordingly the CD spectra of d(TnsoT),
Scheme 6
d(TnsnT) and d(TpT) were recorded across a range of diﬀerent
temperatures (Fig. 1). The spectra for all three dimers were
similar with a strong positive band at 280 nm, a strong negative
band at 255 nm, and a weak positive band at 225 nm. This
suggests that all of the dinucleosides adopt similar overall
conformations. In addition for each sample the major bands at
280 and 255 nm showed a signiﬁcant decrease in intensity as the
temperature was increased. This shift is attributed to a change
from a predominately base-stacked conformation at lower
temperature to a random conformation, with little or no base
stacking, at higher temperatures.39 Signiﬁcantly the change in
the signal intensity of the major bands for d(TnsoT) was twice
the magnitude of that observed for the native d(TpT) across a
similar temperature range. On the other hand the change in
intensity of the bands for d(TnsnT) was very similar to d(TpT).
Thus d(TnsoT) appears to have a greater propensity to adopt a
base-stacked helical conformation at lower temperature than do
either d(TnsnT) or d(TpT). In summary both 3-N-sulfamate
Fig. 1 The eﬀects of changing temperature on the CD spectra of
d(TnsoT) 30, d(TnsnT) 31 compared with that of the native d(TpT).
Table 1 Conformation of the sugar rings in 3-N-sulfamate dinucleo-
side d(TnsoT) 30, between 70 and 10 C, compared with the sulfamide
dinucleoside d(TnsnT) 31 and the native dinucleotide d(TpT) 22
 Σ1 a/Hz (%N) b
Temp./C 70 50 30 10
d(T nsoT) c 30 12.0 a (63) b 11.8 (66) 11.6 (69) 11.1 (78)
d(TnsoT ) 12.9 (47) 13.1 (44) 13.1 (44) 12.7 (51)
d(T nsnT) 31 22 12.3 (58) 12.1 (61) 11.8 (66) 11.2 (76)
d(TnsnT ) 13.4 (39) 13.3 (40) 13.2 (42) 13.1 (44)
d(T pT) 13.7 (34) 13.7 (34) 13.6 (36) 13.4 (39)
d(TpT ) 13.6 (36) 13.6 (36) 13.6 (36) 13.6 (36)
a The sum of the H1 vicinal coupling constants Σ1 = J12  J12. b The
% of N-conformer in the N–S conformational equilibrium was deter-
mined from the Altona sum rule32 % S = 100(Σ1  9.8)/5.9. c Each row
refers to the sugar ring italicised with the 5- and 3-terminal sugars
indicated to the left and right, respectively. 
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and sulfamide modiﬁcation of the dinucleoside phosphate d-
(TpT) result in a shift towards a preferred C3-endo deoxyribose
conformation. However, only the 3-N-sulfamate modiﬁcation
appears to increase the extent with which the bases can adopt a
stacked conformation. It is now well established that modiﬁ-
cations to oligodeoxynucleotides that increase the proportion
of C3-endo deoxyribose rings and increase the propensity of
the single strand to base stack are better preorganised into
an helical conformation required for the formation of
stable hybrid duplexes with complementary RNA as well as
DNA.1 It can therefore be expected that sulfamide- and,
particularly, 3-N-sulfamate-modiﬁed oligodeoxynucleotides
will be well disposed to form duplexes with complementary
nucleic acids.
Modiﬁed-oligonucleotide synthesis and nucleic-acid-binding
studies
To investigate the eﬀects of 3-N-sulfamate and sulfamide
modiﬁcations on the stability of nucleic acid duplexes we chose
to incorporate the modiﬁed linkages into the DNA sequence
d(GCGT10GCG) using the block-synthesis approach. This
sequence has been used extensively by others and gives fairly
representative results for comparison of the eﬀects of modiﬁ-
cations on duplex melting temperatures.40 Accordingly, chim-
eric oligodeoxynucleotide 16mers, with between one and ﬁve
central 3-N-sulfamate (nso) or sulfamide (nsn) linkages 39–43
(Table 2), were synthesised. The synthesis was carried out using
an automated DNA synthesiser with standard nucleoside
phosphoramidites and the modiﬁed dimer phosphoramidites
35 and 37. The 2-ﬂuorouridine-modiﬁed sulfamide dimer 36
was also used to synthesise oligonucleotides 44 and 45 con-
taining 1 and 3 central 2-ﬂuorouridine-sulfamide modiﬁ-
cations (UFnsnT). Standard phosphoramidite protocols for
DNA synthesis were used throughout, with the added pre-
caution of increased coupling times of 15 minutes for the
modiﬁed dimers. Coupling eﬃciencies for monomer and modi-
ﬁed dimers was in excess of 98% as determined by measuring
the release of the dimethoxytrityl cation spectrophoto-
metrically. Following deprotection and cleavage from the solid
support, with aq. ethanolic ammonia, the oligonucleotide
ammonium salts were puriﬁed by RP-HPLC and converted to
the sodium forms using an ion-exchange resin. All the modiﬁed
oligonucleotides were subjected to electrospray mass spec-
trometry and the observed masses of the parent ions were all in
close agreement with the calculated values (Table 2).
Following this the UV absorption at 260 nm vs. temperature
curves for equimolar mixtures (3 µM strand concentrations) of
the native d(GCGT10GCG) 38 and modiﬁed oligonucleotides
(39–45) with complementary DNA and RNA (CGCA10CGC)
were recorded. All mixtures were prepared in phosphate buﬀer
(pH 7.0) adjusted to either 0.02, 0.1 or 1.0 M total sodium ion
Table 2 Electrospray mass spectrometry data for native 38 and
modiﬁed oligonucleotides 39–45
 
Electrospray
MS/Da
Oligo. (Calc.d) (Found)
38 d(GCGT10GCG) 4875.2 4875.3
39 d(GCGT4TnsoTT4GCG)
a 4874.3 4874.2
40 d(GCGTnsoTTTTnsoTTTTnsoTGCG) 4872.5 4872.5
41 d(GCGTnsoTTnsoTTnsoTTnsoTTnsoTGCG) 4870.7 4870.6
42 d(GCGT4TnsnTT4GCG)
b 4873.3 4872.8
43 d(GCGTnsnTTTTnsnTTTTnsnTGCG) 4869.5 4869.7
44 d(GCGT4U
FnsnTT4GCG)
c 4877.3 4876.7
45 d(GCGUFnsnTTTUFnsnTTTUFnsnTGCG) 4881.4 4881.1
a A single 3-N-sulfamate nucleoside linkage is indicated by the abbrevi-
ation nso. b Sulfamide linkage (nsn). c 2-Fluorouridine (UF). 
concentration. Each UV melting curve exhibited typical hyper-
chromicity, between 10 and 25%, with a single transition con-
sistent with the melting of a duplex to single strands. Typical
melting curves obtained from thermal denaturation with
complementary DNA and RNA are shown in Fig. 2 and 3,
respectively, in the electronic supplementary information that
accompanies this paper. †The maximum of the ﬁrst derivative
of these curves was then used to determine the duplex melting
temperatures (T ms) (Table 3). This revealed that modiﬁed
oligonucleotides with 1 and 3 central sulfamide linkages (42
and 43) form less stable duplexes with complementary DNA,
exhibiting a drop in T m per modiﬁcation (∆T m/mod.), com-
pared with the native duplex, of ca. 3.2 C at 0.02 and 0.1 M
salt concentration [Na]. Increasing the salt concentration
to 1.0 M Na results in a more marked drop in T m of the
sulfamide-modiﬁed duplexes, compared with the native duplex,
of up to 5.5 C ∆T m/mod. Furthermore, 2-ﬂuorouridine-
sulfamide modiﬁcations in oligonucleotide 44 and 45 produced
an even larger drop in T m of between 5.8 and 6.4 C per
modiﬁcation with DNA at 0.1 M Na. In contrast, oligo-
nucleotides with 1, 3 or 5 sulfamate modiﬁcations (39, 40
and 41) formed duplexes with complementary DNA that were
moderately more stable than the native duplex at low salt con-
centration (0.02 M Na) with an observed increase in T m of
0.3 C per modiﬁcation. At 0.1 M Na the 3-N-sulfamate-
modiﬁed oligonucleotides 39–41 formed duplexes of com-
parable stability to the native duplex, whilst at higher salt
concentration (1.0 M Na) the T m dropped by 0.4 C for one
3-sulfamate modiﬁcation.
The observed changes in ∆T m per modiﬁcation with change
in salt concentration for 3-N-sulfamate-modiﬁed DNA
duplexes can be explained by the reduction in net negative
charge of the oligonucleotide backbone upon introduction
of neutral linkages. The resulting reduction in electrostatic
repulsion between complementary strands will, when all other
things are equal, stabilise the duplex that is formed. Clearly
this eﬀect will be more signiﬁcant at low salt concentration
when fewer sodium cations are present to mask the negatively
charged phosphodiester groups. In the case of the sulfamide
modiﬁcations (42 and 43) any favourable eﬀects due to reduc-
tion in backbone negative charge are probably outweighed by
an unfavourable change in conformation, which results in a
suboptimal structure for formation of a Watson–Crick base-
paired duplex. Nevertheless, the destabilisation of the duplex
formed between sulfamide-modiﬁed oligonucleotides 42 or 43
and DNA is still greatest at higher salt concentration when
electrostatic repulsion is less signiﬁcant.
Table 3 Duplex melting temperatures of 3-N-sulfamate and
sulfamide-modiﬁed oligonucleotides with complementary DNA and
RNA
 T m
a (∆T m/mod.)
b/C
 DNA c RNA d
Oligo. 0.02 M [Na] 0.1 M [Na] 1.0 M [Na] 0.1 M [Na]
38 43.2 a 55.0 66.4 49.0
39 43.6 a (0.4) b 55.1 (0.1) 66.0 (0.4) 47.8 (1.2)
40 44.0 (0.3) 55.5 (0.2) N.D.e 48.0 (0.3)
41 44.8 (0.3) 53.3 (0.3) N.D. 46.0 (0.6)
42 40.0 (3.2) 51.7 (3.3) 60.9 (5.5) 45.9 (3.1)
43 33.7 (3.2) 45.0 (3.3) 54.6 (3.9) 41.0 (2.7)
44 N.D. 49.2 (5.8) N.D. N.D.
45 N.D. 35.8 (6.4) N.D. N.D.
a Duplex melting temperature (T m). 
b Figures in parentheses represent
the change in T m per modiﬁcation (∆T m/mod.) compared with the
native duplexes. c Data recorded with complementary DNA d(CG-
CA10CGC) at low, intermediate and high salt concentration. 
d Data
recorded with complementary RNA r(CGCA10CGC) at intermediate
salt concentration. e N.D.: T m not determined. 
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The sulfamide modiﬁcations in oligonugleotides 42 and 43
has a similar eﬀect on duplex stability with complementary
RNA at 0.1 M salt concentration, resulting in a drop in T m of
ca. 3.0 C per modiﬁcation. In the case of the 3-N-sulfamate-
modiﬁed oligonucleotides the heteroduplexes formed with
RNA were slightly less stable than the isosequential modiﬁed
DNA duplexes. At intermediate salt concentration with 3 and 5
sulfamate modiﬁcations a moderate drop in T m per modiﬁ-
cation of 0.3 and 0.6 C, respectively, was observed with a
larger drop in T m of 1.2 C recorded for one modiﬁcation. In
light of the earlier NMR observations with 3-N-sulfamate
dinucleoside d(TnsoT), it seems likely that the more 3-N-
sulfamate linkages incorporated into the oligodeoxynucleotide
the higher the proportion of C3-endo deoxyribose rings that
are present. As a consequence of this, oligonucleotides which
are more highly substituted with 3-N-sulfamate groups are
more likely to adopt an overall A-type conformation which is
preferred for binding to complementary RNA. Furthermore we
anticipate that oligodeoxynucleotides that are fully modiﬁed
with, or possess a longer continuous stretch of, 3-N-sulfamate
modiﬁcations will have greater conformational homogeneity
and increased aﬃnity for RNA.
Taken overall these results clearly show that 3-N-sulfamate-
modiﬁed oligonucleotides 39–41 hybridise with both comple-
mentary RNA and DNA with similar binding aﬃnity as native
DNA. On the other hand the sulfamide congeners 42 and 43
have signiﬁcantly lower aﬃnity for both complementary nucleic
acids. Given that both modiﬁcations are neutral and result in a
similar shift in the sugar pucker towards a preferred C3-endo
conformation it seems that other conformational factors
are responsible for the signiﬁcant diﬀerences in aﬃnity. Indeed
the additional incorporation of an highly electronegative 2-
ﬂuorine substituent in sulfamide-modiﬁed oligonucleotides 44
and 45 would be expected to increase further the bias of the
modiﬁed sugar rings towards a locked C3-endo conformation.
Yet this combination of modiﬁcations proved to be most detri-
mental to the formation of duplexes with complementary
DNA. Furthermore CD spectra recorded for both sulfamide
and 3-N-sulfamate dinucleosides 30 and 31 indicate that the
3-sulfamate-modiﬁed oligonucleotides are probably better
preorganised into a base-stacked helical conformation, in the
single stranded state. This would reduce the loss of entropy on
binding to complementary RNA and DNA and account for the
greater stability of 3-N-sulfamate-modiﬁed duplexes. Also the
nitrogen atoms in the 3-N-sulfamate and -sulfamide linkages
are likely to be tetrahedral in geometry and thus are able to
adopt diﬀerent conﬁgurations that will diﬀer in the orientation
of the N–H bonds.23 Given that there are two such nitrogen
atoms in the sulfamide linkage and given that the energy barrier
to inversion of conﬁguration is likely to be low,23 it is tempting
to postulate that the sulfamide linkage will be intrinsically
more ﬂexible than the 3-sulfamate linkage. If that were the
case it would also point towards there being a larger loss of
entropy on formation of a duplex with sulfamide modiﬁed
oligonucleotides.
It is also interesting to note that 3-N-sulfamate-modiﬁed
oligonucleotides display higher aﬃnity for complementary
DNA than do oligonucleotides incorporating isomeric 5-N-
sulfamate linkages,26 with a 5-amino rather than a 3-amino
substituent. According to an earlier report a DNA duplex
with 5-N-sulfamate modiﬁcations exhibited in a drop in T m of
1.5 C per modiﬁcation.26 It is likely that the 5-amino
substituent common to both sulfamide and 5-N-sulfamate
modiﬁcations is responsible for the destabilisation of duplexes
with complementary nucleic acids. A similar but more dramatic
eﬀect has been observed with isosteric and isoelectronic
phosphoramidate DNA.35,41 3-N-Phosphoramidate oligo-
nucleotides form very stable duplexes with complementary
DNA and RNA, but the isomeric 5-N-phosphoramidates with
the linkage in the opposite orientation are unable to base
pair or form duplexes under any conditions.35,41 A number of
explanations have been put forward to account for this. First,
modelling studies suggest that the 5-NH group is less well
solvated than the 3-NH group.41 Secondly, from X-ray crystal-
lographic data of a 3-N-phosphoramidate-modiﬁed duplex, it
is postulated that a steric clash between the 5-amino hydrogen
atom and the H2 atom of an adjacent deoxyribose ring would
destabilise a typical A-type duplex.35 Similarly a steric clash of
5-NH with the pyrimidine H6 or deoxyribose O4 atoms would
destabilise a B-type duplex.
Conclusions
Following on from earlier work 22 we have developed an
improved synthesis of sulfamide dinucleosides and a new syn-
thetic route for the preparation of 3-N-sulfamate-modiﬁed
dinucleosides. The synthesis uses 4-nitrophenyl chlorosulfate, a
simple yet hitherto little utilised reagent, to prepare nucleosides
with 4-nitrophenyl 3- and 5-sulfamate groups (18, 22 and 27)
which couple smoothly with alcohol or amine functionalities
of other nucleosides. Whilst yields are typically high, coupling
times with alcohols were in excess of 12 hours. As a result of
this it is likely that more reactive aryl sulfamates, for example
2,4-dinitrophenyl sulfamates corresponding to 18, are required
as monomers for future iterative solid-phase synthesis of the
most promising 3-N-sulfamate-modiﬁed oligonucleotides.
Using NMR and CD we have also established the eﬀects of
both sulfamide and 3-N-sulfamate modiﬁcations on dinucleo-
tide conformation. Notably both modiﬁcations result in a shift
from a preferred C2-endo to C3-endo sugar conformation, but
only the 3-N-sulfamate modiﬁcation results in an increase in
the proportion of base-stacked dimers.
Modiﬁed sulfamide and 3-N-sulfamate dinucleoside phos-
phoramidites were incorporated into a DNA 16mer using the
block-synthesis approach. This enabled the eﬀects of both
modiﬁcations on duplex stability to be determined using
UV thermal denaturation experiments. Whilst the sulfamide
modiﬁcation results in a signiﬁcant destabilisation of duplexes,
the 3-N-sulfamate group has little eﬀect compared with the
native duplexes and even stabilises DNA duplexes at low
salt concentration. Moreover the aﬃnity of 3-N-sulfamate-
modiﬁed oligonucleotides for complementary DNA and RNA
compares favourably with other neutral linkages that have been
used to replace the phosphodiester group in oligonucleotides.
In fact the methylene(methylimino)- (MMI) 16 2, amide- 2 3 and
3-thioformacetal- 17 4 modiﬁed oligonucleotides (Scheme 1),
which are amongst the best neutral modiﬁcations of this type
that have been developed, show similar or only moderately
higher aﬃnity for complementary nucleic acids.40 Moreover the
chemistry described in this paper indicates that 3-N-sulfamate-
modiﬁed oligonucleotides can be prepared more easily and
economically than some of the other modiﬁed oligonucleotides
with neutral linkages. Thus 3-N-sulfamate-modiﬁed oligo-
nucleotides are worthy of further development for application
as antisense or antigene therapeutic agents. In addition the
3-N-sulfamate group is sterically, electronically and probably
conformationally more similar to the phosphodiester group
than are all the other neutral linkages that have been developed
so far. This is reﬂected in minimal disruption of nucleic acid
duplexes as evidenced from the T m results presented here.
As a consequence the 3-N-sulfamate modiﬁcation may ﬁnd
use as a general phosphodiester replacement for other appli-
cations. For example, it might be possible to probe important
contacts between the nucleic acid backbones and speciﬁc
amino acid residues in nucleic acid–protein complexes by
selectively replacing phosphodiester groups with the 3-N-
sulfamate linkages.19 Alternatively, aptamers selected in vitro
for binding to therapeutically relevant protein targets could be
stabilised against nuclease digestion by replacing phospho-
diester groups, which were not involved in electrostatic contacts
490 J. Chem. Soc., Perkin Trans. 1, 2002, 485–495
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with the protein residues, with 3-N-sulfamate groups.8,9 Simi-
larly it may be possible to stabilise hammerhead ribozymes
using 3-N-sulfamate groups, whilst retaining catalytic activity,
for use in vivo.10,11
Experimental
General procedures
1H NMR spectra were recorded at 270, 400 or 500 MHz. 13C
NMR spectra were recorded at 67.9, 100.6 or 125.7 MHz.
Chemical shifts are reported in parts per million relative to
Me4Si or residual solvent signal. J-values are given in Hz. 
19F
NMR spectra were recorded at 188.2 MHz unreferenced.
31P NMR spectra were recorded at 161.9 or 202.4 MHz with
H3PO4 as external standard. FAB mass spectra were obtained
on a ZAB-SE VG Analytical Fisons Instrument. IR spectra
were acquired on a Perkin-Elmer 783 or 1710 FT instrument
for samples as KBr disks or CHCl3 solutions. Melting
points were determined using a Cambridge Instrumental
microscope with a Reichert-Jung heating mantle and are
uncorrected. Flash silica column chromatography was carried
out over Merck Kieselgel 60 (230–400 mesh), and Merck
Kieselgel 60 F254 0.25 mm plates were used for analytical
TLC. Reactions involving anhydrous conditions were carried
out in ﬂame-dried glassware under a positive pressure of
argon. All solvents were distilled before use. Reagents were
puriﬁed and solvents dried using standard procedures.42
Petroleum ether refers to the fraction with distillation range
40–60 C.
NMR and CD studies of modiﬁed and native dinucleotides
1D and 2D NMR spectra for the 3-N-sulfamate-modiﬁed
dinucleoside d(TnsoT) 30 were recorded at 500 MHz and
assigned in an analogous fashion to that described in our earlier
paper.22 CD spectra were measured with either a JASCO
600 or 720 spectropolarimeter complemented with ordinary
UV adsorption measurements employing an AVIV 17DS
spectrophotometer. Sample temperatures were controlled by a
Hewlett-Packard 89090A temperature unit via a temperature
probe. Samples were dissolved in buﬀer adjusted to pH 7.0 con-
taining 3.75 mM NaH2PO4, 1 mM EDTA and 0.1 M NaCl.
Oligonucleotide synthesis and electrospray mass spectrometry
Solid-phase supports and standard nucleoside phosphoramid-
ites were purchased from Glen Research (Virginia, USA).
0.1 M Phosphoramidite solutions in anhydrous acetonitrile
were prepared and oligonucleotides were synthesised auto-
matically on an ABI (Foster City, CA, USA) 392 DNA/RNA
synthesiser using standard procedures. 1 µM Syntheses were
performed for native and 0.2 µM for oligonucleotides incor-
porating modiﬁed dimers. Coupling wait times were extended
to 60 s for native monomer phosphoramidites and 15 min
for modiﬁed dimer phosphoramidites 35–37. 4,5-Dicyano-
imidazole (0.25 M in acetonitrile) was used as the activator.
Coupling eﬃciencies for oligonucleotide synthesis were
measured using an on-line dimethoxytrityl cation detector.
Final deprotection was carried out using a mixture of conc. aq.
ammonia and absolute ethanol (3 : 1 v/v) for 4 hours at 55 C.
Solutions were evaporated to dryness before being recon-
stituted in Ultrapure water and ﬁltered using a Millex®-GS
0.22 µm ﬁlter unit. Puriﬁcation was achieved by HPLC using a
Hamilton polystyrene reversed-phase PRP-1 HPLC column
(250 × 21.5 mm) and the following elution protocol: Solvent A
was 10 mM aq. tetrabutylammonium phosphate (TBAP),
pH 7.5; solvent B was 10 mM TBAP, pH 7.5, in MeCN–water
(8 : 2, v/v); elution with a convex gradient of 5–95% of solvent
B in A in for 40 min at a ﬂow rate of 5 mL/min1. Fractions
containing the oligonucleotide products 38–45 were evaporated
to dryness and then re-dissolved in Ultrapure water and
desalted on a Sep-Pak C18 cartridge. The desalted oligonucleo-
tide was then exchanged for the Na-form using Dowex®
50WX8 wet ion-exchange resin stirring for 45 min at 4 C before
being ﬁltered and evaporated to dryness. Two ten-fold dilutions
were then carried out for each sample, and the absorbance (A)
was determined using a UV spectrophotometer. Electrospray
ionisation mass spectrometry of oligonucleotides was per-
formed on a Q-Tof (Micromass, Altrincham, Manchester,
UK). The electrospray capillary potential was 2.5–3.2 kV and
the cone was held at 47 V. All samples were introduced via
constant infusion at 0.5 µL min1 using a syringe driver
(Harvard Apparatus). Samples were dissolved in a water–
acetonitrile solution (typically 1 : 1 v/v) with 0.1% ammonium
acetate. For all infusion experiments a scan rate of 100 m/z-
units per second was used and the data were collected in ‘multi-
channel analyser’ mode. Data were typically accumulated for
2 minutes depending on the signal intensity.
UV thermal denaturation experiments
Phosphate buﬀer solutions were prepared in doubly distilled
water and consisted of 10 mM NaH2PO4 (pH 7.0), 0.1 mM
EDTA and a total sodium ion concentration of either
0.02, 0.1 or 1.0 M, following addition of NaCl. Buﬀers for
experiments involving RNA were prepared in water pretreated
with diethyl pyrocarbonate (DEPC) and heated at 180 C
overnight. For all UV thermal denaturation experiments
9 nmol of each strand was mixed and the solution was
evaporated. Samples were then reconstituted in the appropriate
buﬀer (3 mL) and transferred to a 1 cm quartz cuvette con-
taining a stirrer bar. A thin layer of silicone oil was placed
over the surface of the sample to eliminate evaporation.
Absorbance vs temperature proﬁles were then recorded on an
HP845A diode array spectrophotometer with an HP89089A
temperature-control unit connected to a Peltier heating block
controlled via a temperature probe placed directly into sample.
Samples were heated at 1.0 C min1 and absorbance values at
260 nm were collected every 0.1 C. The ﬁrst derivative of
the absorption vs. temperature curve was calculated and used
to determine duplex melting temperatures (T ms). All data
acquisition and manipulation was carried out using HP UV
Chemstation software.
4-Nitrophenyl chlorosulfate 16 27,28
A solution of 4-nitrophenol (1.39 g, 10 mmol) and pyridine
(0.81 mL, 10 mmol) in Et2O (10 mL) was added dropwise to
a solution of SO2Cl2 (0.80 mL, 10 mmol) in Et2O (10 mL) at
78 C under argon. The mixture was allowed to warm to room
temperature, stirred for 4 h, and then ﬁltered through Celite.
The solvent was evaporated under reduced pressure and the
resulting orange crystalline solid was recrystallised at 78 C
from a mixture of CH2Cl2 and petroleum ether to give 16 (1.82
g) as a low-melting, pale yellow solid. The mother liquor was
evaporated and the residue was puriﬁed by ﬂash chromato-
graphy (CH2Cl2–petroleum ether 1 : 1) to give further product
16 (147 mg) in 83% overall yield: νmax(KBr)/cm
1 3080, 3120
(Ar–CH), 1535 (NO2), 1490 (Ar), 1430 (SO2), 1350 (NO2), 1210,
1180, 1150 (SO2); δH (270 MHz; CDCl3) 7.61 (2H, d, J 9.2,
H2/6), 8.39 (2H, d, J 9.2, H3/5); δC (67.9 MHz; CDCl3) 122.9
(C2/6), 126.0 (C3/5), 147.5 (C4), 153.5 (C1); m/z (FAB) 238
([M(35Cl)  H], 100%), 240 ([M(37Cl)  H], 35); HRMS m/z
(FAB) 237.9590 ([M(35Cl)  H], [C6H5ClNO5S
35] requires
m/z, 237.9577).
4-Nitrophenyl 5-O-(4,4-dimethoxytrityl)-3-deoxythymidine-
3-sulfamate 18
A solution of 3-amine 15 (54 mg, 0.10 mmol), 4-nitrophenol
(139 mg, 1.00 mmol) and Et3N (170 µL, 1.22 mmol) in CH2Cl2
J. Chem. Soc., Perkin Trans. 1, 2002, 485–495 491
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(0.4 mL) was added dropwise to a solution of chlorosulfate 16
(48 mg, 0.20 mmol) in CH2Cl2 (0.1 mL) at 78 C under argon.
After being stirred for 30 min the reaction mixture was allowed
to warm to room temperature, diluted with CH2Cl2 (5 mL), and
washed with 1 M aq. NaH2PO4 (3 × 5 mL). The aqueous layers
were then re-extracted with CH2Cl2 (2 × 5 mL) and the com-
bined organic extracts were dried over MgSO4 and evaporated
under reduced. The resulting residue was puriﬁed by ﬂash
chromatography, eluting with 10% EtOAc in CH2Cl2 followed
by 1 2% MeOH in CH2Cl2 to give sulfamate 18 (51 mg, 68%)
as a white foam, νmax(KBr)/cm
1 2940–3400 br (NH), 1693 br
(CO), 1530, 1349 (NO2), 1255, 1180 (SO2); δH (500 MHz;
CDCl3) 1.49 (3H, d, J 1.1, CH3), 2.43 (1H, ddd, J 13.5, 5.4 and
1.4, Ha2), 2.50 (1H, ddd, J 13.5, 9.4 and 7.3, Hb2), 3.40 (1H,
dd, J 10.8 and 2.5, Hb5), 3.56 (1H, dd, J 10.8 and 2.8, Ha5),
3.78 (6H, s, 2 × OCH3), 4.34 (1H, ddd, J 2.8, 2.5 and 2.0 Hz,
H4), 4.38 (1H, ddd, J 7.3, 2.0 and 1.4, H3), 6.55 (1H, dd, J 9.4
and 5.4, H1), 6.82–6.87 (4H, m, ArH), 7.23–7.33 (9H, m,
ArH), 7.37–7.41 (2H, m, ArH), 7.59 (1H, d, J 1.1, H6), 8.20
(2H, d, J 9.1, ArH), 8.37 and 8.88 (each 1H, br, NH); δC (125.7
MHz; CDCl3) 11.8 (CH3), 37.9 (C2), 55.3 (2 × OCH3),
56.1 (C3), 64.1 (C5), 84.2, 85.0, 87.5 [C1, C4, OC(Ar)3],
113.2 (C5), 113.4, 122.6, 125.5, 127.3, 127.8, 128.0, 128.1,
129.1, 130.0, 130.1, 134.5, 135.0, 135.1 (12 × ArC and C6),
144.1, 146.0 (2 × ArC), 151.5 (C2), 154.1, 158.9 (2 × ArC),
162.5 (C4).
Symmetrical dimer 19
In the absence of excess of Et3N and 4-nitrophenol the reaction
of 3-amine 15 and chlorosulfate 16, according to the procedure
described above, gave the symmetrical dimer 19 as the major
product (58% yield), νmax(KBr)/cm
1 2860 br (NH), 1700 br
(CO), 1610, 1510 (Ar), 1255 (SO2); δH (400 MHz; CDCl3)
1.59 (6H, s, 2 × CH3), 2.45 (4H, m, 2 × H2/H2), 3.20 (2H, m,
2 × Ha5), 3.40 (2H, m, 2 × Hb5), 3.73 (12H, s, 4 × OCH3), 3.80
(2H, m, 2 × H3), 4.08 (2H, m, 2 × H4), 6.25 (2H, br s,
NHSO2NH), 6.40 (2H, m, 2 × H1), 6.79–7.37 (26H, m,
DMTr), 7.56 (2H, 2 × H6), 9.38 (2H, 2 × imide NH); δC (100.6
MHz; CDCl3) 12.2 (2 × CH3), 30.1 (2 × C2), 55.0 (2 × C3),
55.6 (4 × OCH3), 64 (2 × C5), 85.0 (br, 2 × C1, 2 × C4), 87.4
(2 × OCAr3), 113.6, 113.7, 127.5, 128.1, 128.2, 128.4, 129.5,
130.4, 135.6, 144.6 (Ar, 2 × C5, 2 × C6), 151.8 (2 × C2), 159.1
(2 × Ar), 164.0 (C4); m/z (FAB) 1172 ([M  Na], 35%), 1149
([M  H], 35) and 303 (Ar3C
, 100); HRMS m/z (FAB)
1171.4019 ([M  Na], C62H64N6O14SNa
 requires m/z,
1171.4099).
3-Amino-5-O-(4,4-dimethoxytrityl)-2-ﬂuoro-2,3-dideoxy-
uridine 21
A solution of 2-ﬂuoro-3-azide 20 30 (900 mg, 1.57 mmol) in
60% aq. pyridine (20 mL) was saturated with H2S gas and left
for 18 h at room temperature. CH3OH (15 mL) was then added
and the reaction mixture was ﬁltered through Celite, evaporated
under reduced pressure, and puriﬁed by ﬂash chromatography,
eluting with a gradient of 0 3% CH3OH in CH2Cl2, to give 2-
ﬂuoro-3-amine 21 (851 mg, 99%) as a yellow solid, mp 107–
109 C; δH (270 MHz; CDCl3) 3.46 (1H, dd, J 11.0 and 2.0 Hz,
Hb5), 3.60–3.69 (2H, m, H3 and H4), 3.72 (6H, s, 2 × OCH3),
3.82 (1H, d, J 11.0, H3), 4.78 (1H, dd, 2JHF 52.4, 
3JHH 3.9, H2),
5.26 (1H, d, J 8.4, H5), 5.94 (1H, d, J 16.4, H1), 6.78 (4H, d,
J 9.0, ArH), 7.17–7.34 (9H, m, ArH), 8.01 (1H, d, J 8.4, H6);
δC (67.9 MHz; CDCl3) 51.8 (d, 
2JCF 18.3, C3), 55.2 (2 × OCH3),
60.5 (C5), 83.3 (C4), 87.0 (CAr3), 88.5 (d, 
2JCF 36.7, C1), 95.9
(d, 1JCF 183.3, C2), 102.5 (C5), 113.3, 123.7, 127.1, 127.9,
128.1, 130.1, 135.2, 135.3, 135.9, 139.8, 144.3, 149.6, 150.1,
158.7 (12 × ArC, C2, C6), 163.3 (C4); m/z (FAB) 680 ([M 
Cs], 16%), 570 ([M  Na], 27), 548 ([M  H], 100), 303
(100); HRMS m/z (FAB) 548.2187 ([M  H], [C30H31FN3-
O6]
 requires m/z, 548.2197).
4-Nitrophenyl 5-O-(4,4-dimethoxytrityl)-2-ﬂuoro-2,3-
dideoxyuridine-3-sulfamate 22
A solution of 4-nitrophenyl chlorosulfate 16 (261 mg, 1.10
mmol) in dry CH2Cl2 (0.5 mL) was added rapidly to a mixture
of 2-ﬂuoro-3-amine 21 (275 mg, 0.50 mmol), 4-nitrophenol
(696 mg, 5 mmol), Et3N (0.83 mL, 6 mmol) and activated 4Å
molecular sieves (≈ 0.5 g) in dry CH2Cl2 (2.5 mL) under argon.
After stirring of the mixture at room temperature for 1 h an
additional equivalent of 4-nitrophenyl chlorosulfate (119 mg,
0.50 mmol) and Et3N (70 µL, 0.5 mmol) in dry CH2Cl2 (230 µL)
was added to the reaction mixture. After a further 2.5 h of
stirring at room temperature, CH2Cl2 (20 mL) was added and
the mixture was washed with 1 M aq. NaH2PO4 (3 × 30 mL).
The aqueous layers were then re-extracted with CH2Cl2 (2 ×
50 mL) and the combined organic extracts were dried over
MgSO4 and evaporated under reduced. Puriﬁcation by ﬂash
chromatography, eluting with 10% EtOAc in CH2Cl2 followed
by a gradient of 10 50% acetone in CH2Cl2, gave 2-ﬂuoro-3-
sulfamate 22 as a pale yellow foam (154 mg, 59% based on
unrecovered starting material 21), νmax(KBr)/cm
1 3310–2860
br (NH), 1690 (CO), 1530, 1350 (NO2), 1255, 1180 (SO2);
δH (500 MHz; CDCl3) 3.61 (1H, dd, J 11.4 and 2.8, Hb5),
3.76 (1H, dd, J 11.4 and 1.8, Ha5), 3.78 (3H, s, OCH3), 3.79
(3H, s, OCH3), 4.12 (1H, ddd, J 10.0, 2.8 and 1.8, H4), 4.73
(1H, ddd, 3JHF 25.2, 
3JHH 9.8 and 4.3, H3), 5.26 (1H, dd,
2JHF 52.0, 
3JHH 4.3, H2), 5.29 (1H, d, J 8.2, H5), 5.99 (1H, d,
3JHF 18.6, H1), 6.82 (4H, m, ArH), 7.23–7.40 (11H, m,
ArH), 7.89 (1H, d, J 8.2, H6), 8.21 (2H, d, J 9.1, ArH),
8.74 (1H, br s, NH); δC (125.7 MHz; CDCl3) 53.9 (d, 
2JCF
16.9, C3), 55.2 (OCH3), 60.2 (C5), 80.7, 87.5 [C3, C(Ar)3],
89.3 (d, 2JCF 35.4, C1), 93.3 (d, 
1JCF 183.3, C2), 102.8
(C5), 113.2, 113.3, 122.2, 125.6, 127.3, 128.1, 128.2, 130.2,
130.3, 134.8, 134.9, 140.2, 144.0, 146.1, 149.8, 154.0, 158.8,
158.9 (16 × ArC, C5, C6), 162.7 (C4); δF (188.2 MHz;
CDCl3) 194.6 (ddd, J 52.0, 25.2 and 18.6); m/z (FAB
)
881 ([M  Cs], 100%), 749 ([M  H], 75); HRMS m/z
(FAB) 881.0852 ([M  Cs], C36H33FN4O11SCs
 requires
m/z, 881.0905).
5-O-(4,4-Dimethoxytrityl)-3-deoxythymidine-3-sulfamoyl-
[3(N) 5(O)]-3-O-(tert-butyldimethylsilyl)thymidine 24
A mixture of sulfamate 18 (32 mg, 0.043 mmol), 5-alcohol 23
(31 mg, 0.087 mmol) and activated 4Å molecular sieves
(≈ 50 mg) in dry CH2Cl2 (110 µL) was stirred at room tem-
perature for 1 h in a sealed Wheaton vial under argon. Et3N
(31 µL, 0.22 mmol) was then added and the reaction mixture
immediately developed a deep yellow colour. After 12 h the
reaction mixture was ﬁltered, and puriﬁed by ﬂash chrom-
atography, eluting with 10% EtOAc in CH2Cl2 followed by a
gradient of 1 3% MeOH in CH2Cl2, to give the sulfamate
dimer 24 (40 mg, 97%) as a white foam, νmax(KBr)/cm
1 3470–
3191 br (NH), 1698 (CO str), 1610, 1510 (Ar), 1275 (Si–C),
1252, 1178 (SO2); δH (500 MHz; CDCl3) 0.07 and 0.08 (each 3H,
s, SiCH3), 0.88 [9H, s, C(CH3)3], 1.42 (3H, d, J 1.2, CH3), 1.76
(3H, d, J 1.2, CH3), 2.21 (1H, ddd, J 13.5, 7.3 and 3.9, Ha2 or
Hb2), 2.41 (1H, ddd, J 13.5, 9.1 and 7.5, Hb2 or Ha2), 2.54
(1H, ddd, J 13.5, 5.4 and 1.6, Ha2 or Hb2), 2.65 (1H, ddd,
J 13.5, 6.7 and 6.7, Hb2 or Ha2), 3.36 (2H, m, Ha5/Hb5), 3.78
(6H, s, 2 × OCH3), 4.06 (1H, ddd, J 5.3, 3.9 and 3.9, H4), 4.26
(2H, m, H4 and Hb5), 4.32 (1H, br s, H3), 4.35 (1H, dd, J 10.7
and 4.0, Ha5), 4.53 (1H, ddd, J 7.7, 3.9 and 3.3, H3), 5.72 (1H,
dd, J 6.7 and 6.7, H1), 6.48 (1H, dd, J 9.1 and 5.4, H), 6.82
(4H, m, ArH), 6.96 (1H, d, J 1.2, H6), 7.21–7.31 (9H, m,
ArH), 7.51 (1H, d, J 1.2, H6), 7.61 (1H, br s, SO2NH), 9.64
and 9.83 (each 1H, br s, imide NH); δC (125.7 MHz; CDCl3)
4.9, 4.8 (2 × SiCH3), 11.7, 12.2 (2 × CH3), 17.9
[SiC(CH3)3], 25.7 [SiC(CH3)3], 38.1, 39.1 (2 × C2), 55.2 (2 ×
OCH3), 55.7 (HNC3), 64.0, 69.0 (2 × C5), 72.3 (OC3),
84.2, 84.3, 85.0, 87.2, 90.9 [2 × C4, 2 × C1, OC(Ar)3], 110.8,
492 J. Chem. Soc., Perkin Trans. 1, 2002, 485–495
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112.5 (2 × C5), 113.3, 127.2, 128.0, 128.1, 130.0, 135.0, 135.1,
135.2, 138.6, 144.2, 150.4, 151.5, 158.8 (9 × ArC, 2 × C2, 2 ×
C6), 163.5, 163.9 (2 × C4); m/z (FAB) 984 ([M  Na],
52%), 961 (M, 17) and 303 (CAr3
, 100); HRMS m/z
(FAB) 984.3470 ([M  Na], C47H59N5O13SSiNa
 requires
m/z, 984.3497).
4-Nitrophenyl 3-O-(tert-butyldimethylsilyl)-5-deoxythymidine-
5-sulfamate 27
A solution of 5-amine 26 (71 mg, 0.20 mmol), 4-nitrophenol
(278 mg, 2.00 mmol) and Et3N (334 µL, 2.40 mmol) in dry
CH2Cl2 (0.8 mL) was added dropwise over a period of 5 min
to a solution of chlorosulfate 16 (95 mg, 0.40 mmol) in dry
CH2Cl2 (0.2 mL) at 78 C under argon. After 1 h the reaction
mixture was allowed to warm to room temperature, diluted
with CH2Cl2 (5 mL), and washed with 1 M aq. NaH2PO4 (2 ×
25 mL). The aqueous layers were then re-extracted with CH2Cl2
(3 × 15 mL) and the combined organic extracts were dried
over MgSO4 and evaporated under reduced pressure. Puriﬁ-
cation by ﬂash chromatography, eluting with EtOAc–
petroleum ether (1 : 4 1 : 1) gave sulfamate 27 (76 mg, 68%)
as a white foam, νmax(CHCl3)/cm
1 3675 br (NH), 1696 (C
O), 1521, 1350 (NO2) 1180 (SO2); δH (270 MHz; CDCl3) 0.04
and 0.06 (each 3H, s, SiCH3), 0.86 [9H, s, C(CH3)3], 1.85 (3H,
d, J 0.8, CH3), 2.17 (1H, ddd, J 13.7, 7.0 and 3.9, Ha2), 2.62
(1H, ddd, J 13.7, 6.9 and 6.9, Hb2), 3.50 (2H, m, H25), 3.99
(1H, dd, J 7.6 and 3.8, H4), 4.47 (1H, ddd, J 7.4, 3.9 and
3.8, H3), 5.78 (1H, dd, J 7.0 and 6.9, H1), 7.01 (1H, d,
J 0.8, H6), 7.43 (2H, d, J 9.4, ArH), 8.22 (2H, d, J 9.4, ArH); δC
(67.9 MHz; CDCl3) 4.9, 4.7 [2 × Si(CH3)2], 12.2 (CH3), 17.8
[SiC(CH3)3], 25.6 [SiC(CH3)3], 39.1 (C2), 45.1 (C5), 72.2
(C3), 85.1, 90.1 (C1 and C4), 111.5 (C5), 122.4, 125.4 (ArC),
138.6 (C6), 145.8 (ArC), 150.4 (C2), 154.7 (ArC), 163.6
(C4); m/z (FAB) 579 ([M  Na], 11%), 557 ([M  H],
34), 431 ([M  C5H5N2O2]
, 28), 418 ([M  C6H4NO3]
, 7);
HRMS m/z (FAB) 557.1766 ([M  H], [C22H32N4O9SSi]

requires m/z, 557.1738).
5-O-(4,4-Dimethoxytrityl)-2-ﬂuoro-2,3-dideoxyuridin-3-
ylsulfamido-[3(N) 5(N)]-3-O-(tert-butyldimethylsilyl)-5-
deoxythymidine 29
Et3N (5 µL, 0.036 mmol) was added to a solution of 2-ﬂuoro-
3-amine 21 (20 mg, 0.036 mmol) and 5-sulfamate 27 (29 mg,
0.052 mmol) in dry THF (200 µL) sealed in a Wheaton vial
under argon. After 3 h the reaction mixture was puriﬁed by
ﬂash chromatography, eluting with EtOAc–CH2Cl2 (1 : 1), to
give sulfamide dimer 29 (28 mg, 80%) as a white solid, mp 135–
137 C; δH (400 MHz; CD3OD) 0.16 (6H, s, 2 × SiCH3), 0.95
[9H, s, C(CH3)3], 1.90 (3H, d, J 1.0, CH3), 2.18–2.30 (2H, m,
T-H22), 3.15 (1H, dd, J 14.1 and 5.0, T-Hb5), 3.21 (1H, dd,
J 14.1 and 4.5, T-Ha5), 3.59 (2H, m, U-H25), 3.80 (3H, s,
OCH3), 3.81 (3H, s, OCH3), 3.94 (1H, m, T-H4), 4.14 (1H,
m, U-H4), 4.43 (1H, ddd, 3JHF 27.1, 
3JHH 10.6 and 4.0,
U-H3), 4.50 (1H, m, T-H3), 5.17 (1H, d, J 8.0, U-H5), 5.30
(1H, dd, 2JHF 52.0, 
3JHH 4.0, U-H2), 5.98 (1H, d, 
3JHF 17.6,
U-H1), 6.22 (1H, dd, J 6.5 and 7.5, T-H1), 6.89 (4H, d,
J 9.0, ArH), 7.21–7.49 (9H, m, ArH), 7.54 (1H, d, J 1.0, T-H6),
8.13 (1H, d, J 8.0, U-H6); δC (100.6 MHz; CD3OD) 4.1
(2 × SiCH3), 12.9 (T-CH3), 19.2 [SiC(CH3)3], 26.7 [SiC(CH3)3],
41.1 (T-C2), 45.5 (T-C5), 54.4 (d, 2JCF 18.3, U-C3), 56.2
(2 × OCH3), 61.9 (U-C5), 74.3, 82.2, 87.1, 87.3 (T-C3, U-C4,
T-C4 and T-C1), 88.8 [C(Ar)3], 91.5 (d, 
2JCF 34.6, U-C1), 94.7
(d, 1JCF 183.4, U-C2), 102.9, 112.3 (T-C5 and U-C5) 114.7,
116.9, 127.5, 128.5, 129.4, 129.9, 131.9, 132.0, 136.9, 137.1,
138.7, 142.8, 146.3 (11 × ArC, U-C6 and T-C6), 152.1, 152.8
(2 × C2), 160.6, 160.7 (2 × ArC), 166.4, 166.8 (2 × C4); m/z
(FAB) 987 ([M  Na], 71%), 964 ([M], 37); HRMS
m/z (FAB) 964.3474 (M, C46H57FN6O12SSi
 requires M,
964.3509).
5-O-(4,4-Dimethoxytrityl)-3-deoxythymidin-3-ylsulfamido-
[3(N) 5(N)]-3-O-(tert-butyldimethylsilyl)-5-deoxythymidine
28 22
A mixture of sulfamate 27 (50 mg, 0.09 mmol), 3-amine 15 (98
mg, 0.18 mmol) and activated 4Å molecular sieves (≈ 75 mg)
in dry CH2Cl2 (225 µL) was sealed in a Wheaton vial under
argon. After being stirred for 12 h the reaction mixture was
ﬁltered and subjected directly to ﬂash chromatography, eluting
with EtOAc–CH2Cl2 (1 : 1), to give sulfamide dimer 28 (72 mg,
83%) as a white foam which was identical to a sample that had
been prepared by an alternative route.22
5-O-(4,4-Dimethoxytrityl)-3-deoxythymidin-3-ylsulfamoyl-
[3(N) 5(O)]-thymidine 32
A solution of 1 M TBAF in THF (1.68 mL, 1.68 mmol) was
added to a solution of sulfamate dimer 24 (538 mg, 0.56 mmol)
in dry THF (1 mL) and the resulting mixture was stirred for 5 h.
EtOAc (60 mL) was then added and the mixture was washed
with 1 M aq. KH2PO4 (3 × 40 mL). The aqueous layers were
then re-extracted with EtOAc (2 × 50 mL) and the combined
organic extracts were dried over MgSO4 and evaporated under
reduced pressure. Puriﬁcation by ﬂash chromatography, eluting
with 1 5% MeOH in CH2Cl2, gave dimer-3-alcohol 32 (444
mg, 94%) as a white foam, νmax(KBr)/cm
1 3450 (OH), 3196
(NH), 1700 (CO), 1610, 1510 (Ar), 1254 and 1177 (SO2);
δH (500 MHz; acetone-d6) 1.48 (3H, d, J 1.2, CH3), 1.78 (3H, d,
J 1.2, CH3), 2.25 (2H, dd, J 6.9 and 5.1, H22), 2.55 (1H, ddd,
J 14.0, 6.7 and 5.2, Ha2), 2.61 (1H, ddd, J 14.0, 8.1 and 6.7,
Hb2), 3.43 (1H, dd, J 10.7 and 2.9, Hb5), 3.45 (1H, dd, J 10.7
and 3.7, Ha5), 4.07 (1H, ddd, J 4.8, 3.7 and 3.5, H4), 4.19 (1H,
m, H4), 4.27 (1H, dd, J 10.9 and 4.8, Hb5), 4.35 (1H, dd,
J 10.9 and 3.5, Ha5), 4.40–4.46 (2H, m, 2 × H3), 6.25–6.30
(2H, m, 2 × H1), 6.89 (4H, m, ArH), 7.21–7.39 (7H, m, ArH),
7.45 (1H, d, J 1.3, H6), 7.49 (2H, m, ArH), 7.59 (1H, d, J 1.2,
H6); δC (125.7 MHz; acetone-d6) 12.2, 12.5 (2 × CH3), 38.8, 40.2
(2 × C2), 55.0 (HNC3), 55.5 (2 × OCH3), 64.0, 70.4 (2 × C5),
71.8 (OC3), 84.2, 84.7, 85.0, 85.8 (2 × C4, 2 × C1), 87.5
[OC(Ar)3], 111.1, 111.2 (2 × C5), 114.0, 127.7, 128.7, 129.0,
131.0 (5 × ArC), 136.3, 136.5, 136.5, 136.6 (2 × ArC, 2 × C6),
145.8 (ArC), 151.2 (2 × C2), 159.7 (ArC), 164.1 (2 × C4); m/z
(FAB) 870 ([M  Na], 25%), 847 ([M  H], 15); HRMS
m/z (FAB) 870.2650 ([M  Na], C41H45N5O13SNa
 requires
m/z, 870.2632).
5-O-(4,4-Dimethoxytrityl)-2-ﬂuoro-2,3-dideoxyuridin-3-
ylsulfamido-[3(N) 5(N)]-5-deoxythymidine 33
A solution of sulfamide dinucleoside 29 (319 mg, 0.331 mmol)
in dry THF (3 mL) was treated with 1 M TBAF in THF (1 mL,
1 mmol). After being stirred for 1.5 h the reaction mixture was
worked up and puriﬁed as described above (24 32) to give the
dimer-3-alcohol 33 (272 mg, 97%) as a white solid, mp 205–208
C; δH (270 MHz; CDCl3) 1.86 (3H, s, CH3), 2.24 (2H, m, H22),
3.10 (1H, dd, J 14.1 and 5.1, Hb5), 3.45 (1H, dd, J 14.1 and
3.9, Ha5), 3.56 (2H, br s, H25), 3.75 (6H, s, 2 × OCH3), 3.87
(1H, dd, J 8.8 and 4.5, T-H4), 4.06 (1H, m, U-H4), 4.25–4.44
(2H, m, 2 × H3), 5.14 (1H, d, J 7.8, H5), 5.21 (1H, dd, 2JHF
52.0, 3JHH 3.9, U-H2), 5.94 (1H, d, 
3JHF 17.6, U-H1), 6.12
(1H, t, J 6.6, T-H1), 6.80–6.83 (4H, d, J 9.0, ArH), 7.16–7.41
(10H, m, ArH and T-H6), 8.04 (1H, d, J 7.8, U-H6); δC (67.9
MHz; CDCl3) 11.2 (CH3), 38.7 (T-C2), 43.5 (T-C5), 52.1
(d, 2JCF 18.3, U-C3), 54.4 (2 × OCH3), 59.6 (U-C5), 70.5
(T-C3), 80.1, 84.0, 85.2, 86.6 (T-C1, 2 × C4, OCAr3), 88.9
(d, 2JCF 36.7, U-C1), 92.5 (d, 
1JCF 187.0, U-C2), 101.4, 110.5
(2 × C5), 112.7, 126.5, 127.3, 127.7, 129.7, 129.8, 134.6, 134.8
(6 × ArC, 2 × C6), 136.4, 140.1, 143.8 (3 × ArC), 149.9 and
150.4 (2 × C2), 158.2, 158.3 (2 × ArC), 163.9, 164.4 (2 × C4);
m/z (FAB) 873 ([M  Na], 15%), 850 (M, 40); HRMS m/z
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(FAB) 873.2549 ([M  Na], C40H43FN6O12SNa
 requires
m/z, 873.2541).
5-O-(4,4-Dimethoxytrityl)-3-deoxythymidin-3-ylsulfamoyl-
[3(N) 5(O)]-3-O-[(2-cyanoethoxy)(diisopropylamino)phos-
phino]thymidine 35
A solution of 0.375 M 2-cyanoethyl N,N,N,N-tetraisopropyl-
phosphoramidite in CH2Cl2 (1.76 mL, 0.66 mmol) was added
to a mixture of 3-alcohol 32 (335 mg, 0.40 mmol) and 4,5-
dicyanoimidazole (47 mg, 0.40 mmol) under argon. After
stirring of the mixture for 12 h CH2Cl2 (20 mL) was added and
the mixture was washed with saturated aq. NaHCO3 (3 ×
20 mL) followed by saturated aq. NaCl (20 mL). The aqueous
layers were then re-extracted with CH2Cl2 (2 × 60 mL) and
the combined organic extracts were dried over MgSO4 and
evaporated under reduced pressure. Puriﬁcation by ﬂash
chromatography, eluting with 1% Et3N in CH2Cl2 then 1% Et3N
in EtOAc, gave a mixture of phosphoramidite diastereoisomers
35 (307 mg, 74%), as a white powder; νmax(KBr)/cm
1 3190
(NH), 2255 (CN), 1690 (CO), 1610, 1512 (Ar), 1255, 1180
(SO2); δH (500 MHz; CDCl3) 1.18 [12H, m, 2 × NCH(CH3)2],
1.46 (3H, br s, 5-CH3), 1.80 (3H, d, 5-CH3), 2.36–2.73 (6H,
m, CH2CN, 2 × H22), 3.39 (2H, m, H25), 3.56–3.64 [2H, m,
2 × NCH(CH3)2], 3.69–3.75 (1H, m, OCHaHbCH2CN), 3.80
(6H, s, 2 × OCH3), 3.84–3.91 (1H, m, OCHaHbCH2CN), 4.23–
4.29 (2H, m, 2 × H4), 4.31–4.46 (3H, m, HNC3H, H25),
4.61–4.69 (1H, m, OC3H), 5.84 and 5.89 (each 0.5H, dd,
H1 diastereoisomers), 6.42–6.47 (1H, m, H1), 6.92 (4H, d,
J 8.8, ArH), 7.02 and 7.05 (each 0.5H, s, H6 diastereoisomers),
7.22–7.42 (9H, m, ArH), 7.51 (1H, s, H6); δC (100.6 MHz;
CDCl3) 11.6, 11.9 (2 × 5-CH3), 20.5 (CH2CN), 24.7, 25.2
[2 × NCH(CH3)2], 38.3, 38.5 (2 × C2), 43.2, 43.4, 43.5 [2 ×
NCH(CH3)2 diastereoisomers], 55.4 (2 × OCH3 and NC3),
58.1, 58.3 (OCH2CH2CN diastereoisomers), 64.1, 69.4 (2 ×
OC5), 73.5, 73.6 (OC3 diastereoisomers), 84.0, 84.4, 87.3,
89.5 [2 × C1, 2 × C4, C(Ar)3], 111.1, 111.3, 112.5 (2 × C5
diastereoisomers), 113.5 (ArC), 118.2 (CN), 127.3, 128.2, 130.2
(4 × ArC), 135.1, 135.3, 135.4 (2 × C6, ArC), 144.4 (ArC),
150.7, 151.5 (2 × C2), 158.9 (ArC), 163.6, 163.9, 164.1 (C4
diastereoisomers); δp (161.9 MHz; CDCl3) 149.2, 149.9 (P
diastereoisomers); m/z (FAB) 1086 ([M  K], 55%), 303
(CAr3
, 100); HRMS m/z (FAB) 1086.3446 ([M  K],
C50H62N7O14PSK
 requires m/z, 1086.3450).
5-O-(4,4-Dimethoxytrityl)-2-ﬂuoro-2,3-dideoxyuridin-3-
ylsulfamido-[3(N) 5(N)]-3-O-[(2-cyanoethoxy)(diisopropyl-
amino)phosphino]-5-deoxythymidine 36
A solution of 0.375 M 2-cyanoethyl N,N,N,N-tetraisopropyl-
phosphoramidite in CH2Cl2 (0.895 mL, 0.34 mmol) was added
to a mixture of 3-alcohol 33 (168 mg, 0.197 mmol) and 4,5-
dicyanoimidazole (23 mg, 0.197 mmol). After stirring of the
solution for 12 h CH2Cl2 (10 mL) was added and the mixture
was worked up and puriﬁed as described above (32 35) to give
a mixture of phosphoramidite diastereoisomers 36 (102 mg,
49%) as a white powder, νmax(KBr)/cm
1 3240 (NH), 2260 (CN),
1690 (CO), 1610, 1512 (Ar), 1255, 1180 (SO2); δH (500 MHz;
CDCl3; 323 K) 1.12–1.20 [12H, m, 2 × NCH(CH3)2], 1.82 (3H,
br s, CH3], 2.37–2.70 (4H, m, CH2CN, H22), 3.40–3.65 [6H, m,
2 × H25 and 2 × NCH(CH3)2], 3.72 (7H, m, 2 × OCH3 and
OCHaHbCH2CN), 3.88 (1H, m, H4), 4.00 (2H, m, NHC3H,
OCHaHbCH2CN), 4.38 (1H, br d, H3), 4.70 (1H, br d, H3),
5.21 (1H, m, H5), 5.26 (1H, d, 2JHF 52, H2), 5.93 (1H, m, H1),
6.15 (1H, m, H1), 6.82 (4H, d, ArH), 7.05–7.45 (9H, m,
ArH), 7.87 (1H, m, H6); δC (100.6 MHz; CDCl3; 298 K) partial
spectrum 12.5 (5-CH3), 20.4 (CH2CN), 24.6 [NCH(CH3)2],
43.2, 43.3 [2 × NCH(CH3)2, 45.8 (T-C5), 52.4 (U-C3), 55.2
(2 × OCH3), 57.8, 59.8 (OCH2CH2CN and U-C5), 80.9, 83.9,
87.2, 88.9 (T-C3, U-C4, T-C4, T-C1, CAr3), 102.1 (C5),
113.7, 127.5, 128.4, 128.6, 130.5, 130.7, 134.5, 144.2, 150.4,
159.0, 159.1, 162.7 (ArC); δp (202.4 MHz; CDCl3; 287 K) 149.2,
150.8 (P diastereoisomers); m/z (FAB) 1089 ([M  K], 90%),
303 (CAr3
, 100); HRMS m/z (FAB) 1089.3377 ([M  K],
C49H60N8O13FPSK
 requires m/z, 1089.3359).
3-Deoxythymidin-3-ylsulfamoyl-[3(N) 5(O)]-thymidine
d(TnsoT) 30
3% CHCl2CO2H in dry CH2Cl2 (0.5 mL) was added to the
3-alcohol 32 (35 mg, 0.041 mmol) under argon. The orange
reaction mixture was puriﬁed immediately by ﬂash chromato-
graphy, eluting with a gradient of 0 10% MeOH in CH2Cl2,
to give d(TnsoT) 30 (17.5 mg, 78%) as a white foam, νmax(KBr)/
cm1 3420 (OH), 3211 (NH), 1691 (CO), 1275, 1180 (SO2);
δH (500 MHz; D2O; 303 K) 1.84 (3H, s, CH3 5-TnsoT -3), 1.85
(3H, s, CH3 5-T nsoT-3), 2.40 (2H, m, H22 TnsoT ), 2.45–2.50
(2H, m, H22 T nsoT), 3.78 (1H, dd, J 12.8 and 3.7, Hb5
T nsoT), 3.91 (1H, dd, J 12.8 and 2.7, Ha5 T nsoT), 3.99–4.06
(2H, m, H3 and H4 T nsoT), 4.19 (1H, ddd, J 4.9, 3.8 and 2.6,
H4 TnsoT ), 4.39 (1H, dd, J 11.1 and 3.8, Hb5 TnsoT ), 4.46
(1H, dd, J 11.1 and 2.6, Ha5 TnsoT ), 4.58 (1H, ddd, J 5.7, 5.7
and 4.9, H3 TnsoT ), 6.07 (1H, dd, J 6.5 and 5.1, H1 T nsoT),
6.28 (1H, dd, J 6.5 and 6.5, H1 TnsoT ), 7.51 (1H, s, H6
TnsoT ), 7.68 (1H, s, H6 T nsoT); δC (125.7 MHz; D2O) 11.5,
11.6 (2 × CH3), 37.1, 38.3 (2 × C2), 51.8 (NHC3), 59.6, 68.7
(2 × C5), 69.5 (OC3), 82.9, 83.8 (2 × C4), 85.0 (2 × C1
coincident), 111.0, 111.3 (2 × C5), 137.0, 137.1 (2 × C6),
151.1, 151.4 (2 × C2), 165.8, 166.1 (2 × C4); m/z (FAB) 568
([M  Na], 35%); HRMS m/z (FAB) 568.1350 ([M  Na],
C20H27N5O11SNa
 requires m/z, 568.1325).
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